Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.

June 05, 2026

Vol.52 No.22

By Sara Willa Ernst, Claire Marie Porter and Paul Goldberg

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally.

June 05, 2026

Vol.52 No.22

By Claire Marie Porter

AI in action: MANAscore tool moves closer to clinic

One of the greatest challenges in cancer immunotherapy is finding the rare immune cells, called tumor-reactive T cells, whose job it is to recognize and eliminate tumor cells.

June 05, 2026

Vol.52 No.22

Cancer Policy

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

The Centers for Medicare & Medicaid Services has released a guidance for states on how to implement Medicaid work requirements that will go into effect nationwide on Jan. 1, 2027.

Advocate Health partners with AI startup to connect more cancer patients to clinical trials

Advocate Health and Lind, an AI-powered clinical reserch platform, are partnering to help connect more cancer patients to clinical trials.

June 05, 2026

Vol.52 No.22

In Brief

OpenEvidence integrates ASCO guidelines, figures, and flowcharts into specialty oncology model

OpenEvidence announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model.

June 05, 2026

Vol.52 No.22

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

YOU MAY BE INTERESTED IN

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

AI in action: MANAscore tool moves closer to clinic

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

Advocate Health partners with AI startup to connect more cancer patients to clinical trials

OpenEvidence integrates ASCO guidelines, figures, and flowcharts into specialty oncology model

Renew today!

Subscriber content

Never miss an issue!

Login

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

YOU MAY BE INTERESTED IN

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

AI in action: MANAscore tool moves closer to clinic

Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail”

Advocate Health partners with AI startup to connect more cancer patients to clinical trials

OpenEvidence integrates ASCO guidelines, figures, and flowcharts into specialty oncology model

Never miss an issue!

Login

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”